Autologous Bone Graft Versus Bone Morphogenetic Protein Augmentation for Comminuted Midshaft Femoral Fractures: A Systematic Review

Andika Prasetyo Arifin; M Yogi Alamsyah; Arimurti Pratianto; Rheza Fabianto Sebastian

doi:10.47134/phms.v3i4.677

Authors

Andika Prasetyo Arifin QADR Hospital
M Yogi Alamsyah Dr. Esnawan Antariksa Air Force Hospital
Arimurti Pratianto Permata Bekasi Hospital
Rheza Fabianto Sebastian QADR Hospital

DOI:

https://doi.org/10.47134/phms.v3i4.677

Keywords:

Autologous Bone Graft, Bone Morphogenetic Protein, Comminuted Fracture, Femoral Shaft Fracture, Fracture Healing, Systematic Review

Abstract

Comminuted midshaft femoral fractures (AO/OTA 32-C2/C3) are complex injuries associated with extensive bone fragmentation, severe soft-tissue damage, and elevated risks of delayed union or nonunion. This systematic review, conducted in accordance with PRISMA guidelines, compared the efficacy and safety of autologous bone grafting (ABG) versus recombinant bone morphogenetic protein (BMP) augmentation as adjuncts to surgical fixation. Comprehensive searches of PubMed, Embase, and Cochrane databases identified twelve comparative studies involving patients treated with internal fixation plus biological enhancement. Primary outcomes included radiographic union rates, time to union, complications, functional recovery, and cost-effectiveness. Risk of bias was assessed using the ROBINS-I tool. Both ABG and BMP achieved high union rates (92% versus 90%), with BMP linked to an approximate two-week reduction in healing time. Substantial heterogeneity across studies, however, precluded definitive conclusions. ABG provided reliable results but was associated with donor-site morbidity in nearly one-fifth of patients. BMP avoided harvest-related complications yet increased risks of heterotopic ossification and soft-tissue edema while incurring significantly higher costs without proven superiority in preventing nonunion or reoperation. In conclusion, both ABG and BMP offer effective biological support for these fractures. Treatment selection should be individualized according to patient characteristics, fracture severity, complication profiles, and resource availability; routine BMP use is not currently justified.

References

Al Wattar, Z., et al. (2024). Recombinant human bone morphogenetic protein in long bone nonunions: A systematic review of efficacy, complications, and cost. Cureus, 16(10), eXXXXX.

Arifin, A. P., Alamsyah, M. Y., Pratianto, A., & Sebastian, R. F. (2026). Autologous bone graft versus bone morphogenetic protein augmentation for comminuted midshaft femoral fractures: A systematic review [Poster presentation]. 74th Continuing Orthopaedic Education of Indonesia Orthopaedic Association. https://www.researchgate.net/publication/404505532

Birner, Z. H., et al. (2021). Radiographic outcomes of femur fractures following SIGN intramedullary nailing in developing countries. OTA International, 4(3), e140. https://journals.lww.com/otainternational/fulltext/2021/09000/radiographic_outcomes_of_femur_fractures_following.6.aspx

Blom, A. W., et al. (2025). Closed fracture middle shaft femur treatments for adolescent: A prospective comparative study. International Journal of Research and Review, 12(1), 406–412.

Brinker, M. R., & O’Connor, D. P. (2020). Fracture nonunion in long bones: A literature review of risk factors and treatment options. Injury, 51(Suppl. 2), S43–S50.

Denisiuk, M., & Afsari, A. (2023). Femoral shaft fractures. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK556057/

Dimitriou, R., Mataliotakis, G. I., Angoules, A. G., Kanakaris, N. K., & Giannoudis, P. V. (2011). Complications following autologous bone graft harvesting from the iliac crest and using the reamer-irrigator-aspirator (RIA): A systematic review. Injury, 42(Suppl. 2), S3–S15.

EAS Journal of Orthopaedic and Physiotherapy. (2024). Autologous bone graft and biologic agents in fracture healing. EAS Journal of Orthopaedic and Physiotherapy, 6(5), 76–81.

Fang, C., Fang, W., Liu, G., et al. (2023). Resistant distal femoral nonunion treated with combined nail/plate construct and autologous bone grafting. Journal of International Medical Research, 51(7), 300605231187945.

Fu, F., et al. (2025). Global trends in the incidence and primary causes of femoral fractures (excluding femoral neck fractures): A global epidemiological study. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC11734506/

Gagnon, D., Mouallem, M., Leduc, S., Rouleau, D. M., & Chapleau, J. (2024). A systematic scoping review of the latest data on orthobiologics in the surgical treatment of non-union. Orthopaedics & Traumatology: Surgery & Research, 110(6), Article 103896. https://www.sciencedirect.com/science/article/pii/S1877056824001348

Ghayyad, K., et al. (2024). Nonunion fractures: Trends in epidemiology and treatment. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC11524799/

Haidukewych, G. J., Koval, K. J., et al. (2025). Modern management of severe open fractures of the extremities. Journal of Bone and Joint Surgery American Volume, 107(3), 245–259.

Hsu, Y. C., Hsu, C. C., Chou, Y. C., et al. (2023). What is the best treatment of the femoral shaft nonunion after intramedullary nailing? A systematic review and network meta-analysis. Journal of Clinical Medicine, 12(13), 4294.

Iheozor-Ejiofor, Z., et al. (2025). The application of ROBINS-I guidance in systematic reviews of non-randomised studies of interventions. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC12873613/

Kanakaris, N. K., Calori, G. M., Verdonk, R., et al. (2008). Application of BMP-7 to long bone nonunions: A 182-patient multicenter study. Journal of Bone and Joint Surgery British Volume, 90(9), 1213–1221.

Kook, I., et al. (2023). A multicenter study of factors affecting nonunion after intramedullary nailing for segmental femoral shaft fractures. Scientific Reports, 13, Article 34939. https://www.nature.com/articles/s41598-023-34939-6

Mastrokostas, P. G., et al. (2025). A step-by-step guide for designing systematic reviews in spine surgery. Journal of Spine Surgery. https://jss.amegroups.org/article/view/7232/html

McFarlane, K., Kiss, A., Rahman, A., et al. (2024). Off-label adjunctive bone morphogenetic protein for challenging femur fractures: Report of two cases. Journal of Orthopaedic Case Reports, 14(1), 42–46.

Medda, S., et al. (2023). Diaphyseal femur fracture. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK493169/

Migliorini, F., et al. (2021). Autologous bone grafting in trauma and orthopaedic surgery: An evidence-based approach. BMC Musculoskeletal Disorders. https://pmc.ncbi.nlm.nih.gov/articles/PMC8509778/

Mohammadi, S. S., et al. (2025). Bone void filler materials for augmentation in comminuted fractures: A comprehensive review. Journal of Orthopaedic Surgery and Research, 20, Article 385. https://link.springer.com/content/pdf/10.1186/s13018-025-05857-2.pdf

Nashi, N., & Kagda, F. H. Y. (2023). Current concepts of bone grafting in trauma surgery. Journal of Clinical Orthopaedics and Trauma, 43, Article 102231. https://pmc.ncbi.nlm.nih.gov/articles/PMC10448478/

Pelegrin-De-Los Santos, W. Y., et al. (2024). Efficacy of bone morphogenetic protein in comparison with autologous bone grafting in long bone nonunions: A systematic review. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC11584972/

Rodham, P. L., et al. (2023). Biological aspects to enhance fracture healing. EFORT Open Reviews, 8(5), 220–228. https://pmc.ncbi.nlm.nih.gov/articles/PMC10233810/

Rodriguez-Merchan, E. C. (2013). Operative treatment for femoral shaft nonunions: A systematic review. International Orthopaedics, 37(9), 1791–1796.

Runzer, C. D. T., et al. (2026). Biologics for bone regeneration: Advances in cell, protein, gene, and small molecule therapies. Bone Research. https://pmc.ncbi.nlm.nih.gov/articles/PMC12791149/

Sakong, S., Hong, S., Choi, W., Kang, S., Cho, J.-W., Son, W. S., Choi, J.-S., Yon, C.-J., Cho, W.-T., & Oh, J.-K. (2026). Safety and efficacy of rhBMP-2 for treating acute traumatic fractures of the upper and lower extremities: A multicenter prospective study. Journal of Clinical Medicine, 15(3), Article 1176.

Sandberg, O., & Aspenberg, P. (2013). Augmentation of autologous bone graft by a combination of bone morphogenetic protein and bisphosphonate increased both callus volume and strength. Acta Orthopaedica, 84(2), 181–185.

Singh, R., Kumar, A., & Gupta, V. (2020). Is there a role of primary bone grafting for comminuted supracondylar femur fractures? International Journal of Orthopaedic Sciences, 6(4), 177–181.

Tonk, G., et al. (2022). Donor site morbidity in autologous bone grafting: A comparison between different techniques of anterior iliac crest bone harvesting: A prospective study. Journal of Orthopaedics, Trauma and Rehabilitation, 29(1). https://journals.sagepub.com/doi/10.1177/22104917221092163

Tressler, M. A., Ziran, B. H., et al. (2011). Bone morphogenetic proteins in orthopaedic trauma surgery. Injury, 42(8), 730–734.

Xiang, Z., Jiang, D., Li, H., et al. (2020). Comparison of bone morphogenetic protein and autologous bone graft for long bone nonunion: A meta-analysis. Medicine, 99(31), e21477.